Xiuying Cai

Dr. Xiuying Cai

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in BMC Neurology
Verified
Journal Article
Open access
PDF file
YWYaya Wu
Yaya Wu
Hui ChenHui Chen
Hui Chen
XLXueyun Liu
Xueyun Liu
XCXiuying Cai
Xiuying Cai
YKYan Kong
Yan Kong
TLTan Li
Tan Li
Background: A reliable scoring tool to detect the risk of intracerebral hemorrhage (ICH) after intravenous thrombolysis for ischemic stroke is warranted. The present study was designed to develop and validate a new nomogram for individualized prediction of the probability of hemorrhagic transformation (HT) in patients treated with intravenous (IV) recombinant tissue plasminogen activator (rt-PA). Methods: We enrolled patients who suffered from acute ischemic stroke (AIS) with IV rt-PA treatment in our emergency green channel between August 2016 and July 2018. The main outcome was defined as any type of intracerebral hemorrhage according to the European Cooperative Acute Stroke Study II (ECASS II). All patients were randomly divided into two cohorts: the primary cohort and the validation cohort. On the basis of multivariate logistic model, the predictive nomogram was generated. The performance of the nomogram was evaluated by Harrell’s concordance index (C-index) and calibration plot. Results: A total of 194 patients with complete data were enrolled, of whom 131 comprised the primary cohort and 63 comprised the validation cohort, with HT rate 12.2, 9.5% respectively. The score of chronic disease scale (CDS), the global burden of cerebral small vascular disease (CSVD), National Institutes of Health Stroke Scale (NIHSS) score ≥ 13, and onset-to-treatment time (OTT) ≥ 180 were detected important determinants of ICH and included to construct the nomogram. The nomogram derived from the primary cohort for HT had C- Statistics of 0.9562 and the calibration plot revealed generally fit in predicting the risk of HT. Furthermore, we made a comparison between our new nomogram and several other risk-assessed scales for HT with receiver operating characteristic (ROC) curve analysis, and the results showed the nomogram model gave an area under curve of 0.9562 (95%CI, 0.9221–0.9904, P < 0.01) greater than HAT (Hemorrhage After Thrombolysis), SEDAN (blood Sugar, Early infarct and hyper Dense cerebral artery sign on non-contrast computed tomography, Age, and NIHSS) and SPAN-100 (Stroke Prognostication using Age and NIHSS) scores. Conclusions: This proposed nomogram based on the score of CDS, the global burden of CSVD, NIHSS score ≥ 13, and OTT ≥ 180 gives rise to a more accurate and more comprehensive prediction for HT in patients with ischemic stroke receiving IV rt-PA treatment.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZLZhuo Liu
Zhuo Liu
XLXueyun Liu
Xueyun Liu
SDShanshan Diao
Shanshan Diao
YKYan Kong
Yan Kong
XDXiaoyu Duan
Xiaoyu Duan
XCXiuying Cai
Xiuying Cai
Background. The correlation between H‐type hypertension and cerebral small‐vessel diseases (CSVD) remains uncertain. Objective. The present study was designed to explore the possible relationship between H‐type hypertension and CSVD spectrum and total burden. Method. We included 329 patients in the present study and divided them into four groups: the H‐type hypertension group, isolated hypertension group, isolated hyperhomocysteinemia (HHcy) group, and control group. Clinical variables of interest and the MR examination sequences were obtained. We counted the presence of each CSVD feature and rated the total burden of CSVD on an ordinal scale from 0 to 4 according to a recent described score rule. Result. The results showed that H‐type hypertension was associated with the presence of cerebral microbleeds (CMBs), and the severity of white‐matter hyperintensities (WMHs) and peripheral vascular space (PVS). CSVD total burden was significantly related to age (OR: 1.059, 95% CI: 1.037–1.082), systolic pressure (OR: 1.122, 95% CI: 1.007–1.136), triglycerides (OR: 1.386, 95% CI: 1.037–1.854), isolated HHcy (OR: 4.154, 95% CI 1.836–9.401), and H‐type hypertension (OR: 5.028, 95% CI: 2.323–10.883). Also, we further observed hypertension and HHcy had a synergistic effect on CSVD total burden (OR: 2.776, 95% CI: 1.564–4.927). Conclusion. H‐type hypertension was associated with CSVD total burden and CSVD spectrum, which deserves further prevention measures. Furthermore, hypertension and HHcy had a synergistic effect on CSVD total burden.

9 September 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TLTan Li
Tan Li
JZJiajia Zhu
Jiajia Zhu
QFqi Fang
qi Fang
XDXiaoyu Duan
Xiaoyu Duan
MZMingzhi Zhang
Mingzhi Zhang
XCXiuying Cai
Xiuying Cai
Background. The correlation between H-type hypertension and acute ischemic stroke remains uncertain. Objective. The present study was designed to explore the possible relationship between H-type hypertension and severity and prognosis of acute ischemic stroke. Method. We included 372 patients with acute ischemic stroke and divided them into four groups: H-type hypertension group, simple hypertension group, simple hyperhomocysteinemia (HHcy) group, and the control group. NIHSS score was measured at both admission and two weeks later. mRS score, stroke recurrence, cardiovascular event, or all-cause mortality was recorded at 3-month and 1-year follow-up. Result. The results showed that the NIHSS score on admission in the H-type hypertension group (6.32 ± 5.91) was significantly higher than that in the control group (3.97 ± 3.59) (P < 0.05), while there was no obvious association between H-type hypertension and NIHSS score after 2-week treatment (P = 0.106). Endpoint events incidence in H-type hypertension group was the highest; however, in the cox regression model of multiple factor analysis, H-type hypertension was not an independent risk factor. Conclusion. H-type hypertension may result in early functional deterioration and higher incidence rate of endpoint events but not act as an independent risk factor.

27 May 2022 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
DGDongsheng Gao
Dongsheng Gao
LMLinqing Ma
Linqing Ma
YXYunliang Xie
Yunliang Xie
BXBo Xiao
Bo Xiao
SXShouru Xue
Shouru Xue
XYXiaoyan Yang
Xiaoyan Yang

1 November 2019 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
JZJuehua Zhu
Juehua Zhu
XSXiahong Shen
Xiahong Shen
CHChunyan Han
Chunyan Han
CMChunhao Mei
Chunhao Mei
YZYun Zhou
Yun Zhou
XCXiuying Cai
Xiuying Cai

28 April 2022 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
ATAnqi Tang
Anqi Tang
SLSanjiao Liu
Sanjiao Liu
ZWZhi Wang
Zhi Wang
HSHan Shao
Han Shao
XCXiuying Cai
Xiuying Cai
TLTan Li
Tan Li